1346456-01-6Relevant articles and documents
Crystal form IX of Tipidogrel free alkali and preparation method and application thereof
-
Paragraph 0076; 0077; 0078, (2016/11/09)
The invention belongs to the technical field of medicine and particularly provides a crystal form IX of (5-(2-cyanobenzy)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate.The invention further provides a preparation method of the crystal form and application of the crystal form in preparation of anti-platelet aggregation pharmaceutical compositions.(Please see the chemical formula in the description.).
Crystal form X of Tipidogrel free alkali and preparation method and application thereof
-
Paragraph 0076; 0077; 0078, (2016/10/27)
The invention belongs to the technical field of medicine and particularly provides a crystal form X of (5-(2-cyanobenzy)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate.The invention further provides a preparation method of the crystal form and application of the crystal form in preparation of anti-platelet aggregation pharmaceutical compositions.(Please see the chemical formula in the description.).
Crystal form II of (5-(2-cyanobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate and preparation method and application thereof
-
Paragraph 0069; 0070; 0071; 0075; 0076; 0077, (2016/11/17)
The invention belongs to the technical field of medicine and particularly provides a following crystal form II of (5-(2-cyanobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-yl)acetate. The invention further provides a preparation method of the above-mentioned crystal form and application of the crystal form in the preparation of pharmaceutical composition for resisting platelet aggregation.